Capital Asset Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Capital Asset Advisory Services’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9	Closed	-$1K	–	424
2022 Q3	$1K	Hold	9	–	–	﹤0.01%	446
2022 Q2	$1K	Hold	9	–	–	﹤0.01%	560
2022 Q1	$1K	Hold	9	–	–	﹤0.01%	555
2021 Q4	$1K	Sell	9 -918	-99%	-$58.2K	﹤0.01%	587
2021 Q3	$57K	Hold	927	–	–	0.01%	501
2021 Q2	$57K	Sell	927 -210	-18%	-$12.8K	0.01%	525
2021 Q1	$67K	Hold	1,137	–	–	0.01%	495
2020 Q4	$68K	Buy	1,137 +36	+3%	+$2.05K	0.01%	545
2020 Q3	$60K	Hold	1,101	–	–	0.01%	368
2020 Q2	$59K	Buy	1,101 +501	+84%	+$25.2K	0.01%	395
2020 Q1	$30K	Buy	600 +591	+6,567%	+$29.8K	0.01%	382
2019 Q4	$0	Buy	+9	New	+$444	﹤0.01%	596

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital Asset Advisory Services's IHE Position: Q4 2022 in Review

Capital Asset Advisory Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2022, closing a stake of 9 shares — an estimated $1K sold.

Capital Asset Advisory Services first reported a position in IHE in Q4 2019 and held it in 12 quarters. The position peaked at $68K in Q4 2020. 130 funds tracked by Wall St. Rank hold IHE as of Q4 2022.

Capital Asset Advisory Services reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
Capital Asset Advisory Services sold 9 iShares US Pharmaceuticals ETF shares in Q4 2022, an estimated $1K.
Capital Asset Advisory Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and held it in 12 quarters.
Capital Asset Advisory Services's iShares US Pharmaceuticals ETF position peaked at $68K in Q4 2020.
130 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2022.

Based on Capital Asset Advisory Services's 13F filing for Q4 2022, filed 8 Mar 2023.